Skip to main content
Fig. 1 | BMC Women's Health

Fig. 1

From: Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

Fig. 1

Flowchart of the VITA trial. a Prescribed lactic acid gel as refused allocated study treatment.b Ineligible as taking warfarin, prescribed lactic acid gel instead.c No study treatment given as participant received medication to treat thrush.d Preferred metronidazole after being randomised to lactic acid gel.e Included as one of the two withdrawn before Week 2 in the next box down.f Includes outcomes obtained from Week 2 questionnaire where a date of resolution was given without an answer to the ‘Have your bacterial vaginosis symptoms cleared’ question, and primary outcome collected by phone. Also includes outcomes obtained from 3 month questionnaire asking about resolution by Week 2.g At least one data item entered on questionnaire. h At least one data item entered on questionnaire or obtained by telephone

Back to article page